Kumar V.S. Nemmani

1.7k total citations
39 papers, 1.2k citations indexed

About

Kumar V.S. Nemmani is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Kumar V.S. Nemmani has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 10 papers in Physiology. Recurrent topics in Kumar V.S. Nemmani's work include Neuropeptides and Animal Physiology (8 papers), Pancreatic function and diabetes (8 papers) and Receptor Mechanisms and Signaling (5 papers). Kumar V.S. Nemmani is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Pancreatic function and diabetes (8 papers) and Receptor Mechanisms and Signaling (5 papers). Kumar V.S. Nemmani collaborates with scholars based in India, Canada and United States. Kumar V.S. Nemmani's co-authors include Jeffrey S. Mogil, Judith E. Grisel, Poduri Ramarao, Ram A. Vishwakarma, Sandip B. Bharate, Alexander Yur'evich Mayorov, Lalit Doshi, Roger B. Fillingim, Toni L. Glover and Victor J. Hruby and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Pain.

In The Last Decade

Kumar V.S. Nemmani

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumar V.S. Nemmani India 20 441 335 237 176 172 39 1.2k
Leila Moezi Iran 21 317 0.7× 256 0.8× 349 1.5× 111 0.6× 241 1.4× 81 1.5k
Lei Sha United States 21 520 1.2× 378 1.1× 152 0.6× 78 0.4× 76 0.4× 65 1.5k
Yue Hou China 25 598 1.4× 178 0.5× 118 0.5× 57 0.3× 139 0.8× 81 1.6k
Beatriz Martín‐Fernández Spain 22 336 0.8× 221 0.7× 243 1.0× 254 1.4× 286 1.7× 55 1.3k
Rafael Villalobos‐Molina Mexico 23 817 1.9× 504 1.5× 384 1.6× 396 2.3× 127 0.7× 101 1.8k
Geeta Negi India 13 558 1.3× 469 1.4× 105 0.4× 172 1.0× 120 0.7× 25 1.5k
Ayat Kaeidi Iran 21 240 0.5× 241 0.7× 235 1.0× 102 0.6× 79 0.5× 76 1.0k
Aron Jurkiewicz Brazil 19 714 1.6× 291 0.9× 358 1.5× 154 0.9× 149 0.9× 122 1.4k
Hong Jiang China 27 660 1.5× 302 0.9× 170 0.7× 101 0.6× 87 0.5× 72 1.9k
Frank Christopher Howarth United Arab Emirates 27 716 1.6× 414 1.2× 256 1.1× 284 1.6× 219 1.3× 110 2.0k

Countries citing papers authored by Kumar V.S. Nemmani

Since Specialization
Citations

This map shows the geographic impact of Kumar V.S. Nemmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumar V.S. Nemmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumar V.S. Nemmani more than expected).

Fields of papers citing papers by Kumar V.S. Nemmani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumar V.S. Nemmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumar V.S. Nemmani. The network helps show where Kumar V.S. Nemmani may publish in the future.

Co-authorship network of co-authors of Kumar V.S. Nemmani

This figure shows the co-authorship network connecting the top 25 collaborators of Kumar V.S. Nemmani. A scholar is included among the top collaborators of Kumar V.S. Nemmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumar V.S. Nemmani. Kumar V.S. Nemmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samudrala, Pavan Kumar, et al.. (2022). Advancing health care via artificial intelligence: From concept to clinic. European Journal of Pharmacology. 934. 175320–175320. 20 indexed citations
4.
Nandakumar, Krishnadas, et al.. (2017). Effect of D-Ala 2 GIP, a stable GIP receptor agonist on MPTP-induced neuronal impairments in mice. European Journal of Pharmacology. 804. 38–45. 21 indexed citations
6.
Sharma, Ankur, et al.. (2014). Gastric-sparing nitric oxide-releasable ‘true’ prodrugs of aspirin and naproxen. Bioorganic & Medicinal Chemistry Letters. 24(24). 5587–5592. 16 indexed citations
7.
Khanna, Smriti, Ashish P. Keche, Usha Ghosh, et al.. (2012). Isocytosine-based inhibitors of xanthine oxidase: Design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia. Bioorganic & Medicinal Chemistry Letters. 22(24). 7543–7546. 45 indexed citations
8.
B‐Rao, Chandrika, Asha Kulkarni‐Almeida, Smriti Khanna, et al.. (2012). Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits. Bioorganic & Medicinal Chemistry. 20(9). 2930–2939. 50 indexed citations
9.
Keche, Ashish P., Usha Ghosh, Smriti Khanna, et al.. (2012). Lead optimization of isocytosine-derived xanthine oxidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(3). 834–838. 29 indexed citations
10.
Kulkarni‐Almeida, Asha, Manoja K. Brahma, K. Narayan Prabhu, et al.. (2011). Fermentation, Isolation, Structure, and Antidiabetic Activity of NFAT-133 produced by Streptomyces strain PM0324667. AMB Express. 1(1). 42–42. 28 indexed citations
11.
Motiwala, Hashim F., Atish H. Rodge, Manoja K. Brahma, et al.. (2011). Exploration of pyridine containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(19). 5812–5817. 10 indexed citations
12.
Doshi, Lalit, Manoja K. Brahma, Sufyan G. Sayyed, et al.. (2009). Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat. Metabolism. 58(3). 333–343. 27 indexed citations
13.
Bhatia, Dimple, Pooja Bhatt, Kumar V.S. Nemmani, et al.. (2009). Synthesis and therapeutic evaluation of pyridyl based novel mTOR inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(11). 2949–2952. 7 indexed citations
14.
Nemmani, Kumar V.S., Jasmin Lalonde, & Jeffrey S. Mogil. (2005). Region-specific changes of calcium/calmodulin-dependent protein kinase IV in the mouse brain following chronic morphine treatment. Neuroreport. 16(9). 879–882. 8 indexed citations
16.
Nemmani, Kumar V.S. & Jeffrey S. Mogil. (2003). Serotonin–GABA interactions in the modulation of mu- and kappa-opioid analgesia. Neuropharmacology. 44(3). 304–310. 35 indexed citations
17.
Gullapalli, Srinivas, Kumar V.S. Nemmani, & Poduri Ramarao. (2002). Role of Ca2+ channels on the hypothermic response produced by activation of κ-opioid receptors. Pharmacology Biochemistry and Behavior. 72(1-2). 93–99. 3 indexed citations
18.
Nemmani, Kumar V.S. & Poduri Ramarao. (2002). Ginsenoside Rf potentiates U-50,488H-induced analgesia and inhibits tolerance to its analgesia in mice. Life Sciences. 72(7). 759–768. 23 indexed citations
19.
Nemmani, Kumar V.S. & Poduri Ramarao. (2002). Ginseng total saponin potentiates acute U-50,488H-induced analgesia and inhibits tolerance to U-50,488H-induced analgesia in mice. Pharmacology Biochemistry and Behavior. 72(1-2). 1–6. 10 indexed citations
20.
Nemmani, Kumar V.S., Srinivas Gullapalli, & Poduri Ramarao. (2001). Potentiation of κ-opioid receptor agonist-induced analgesia and hypothermia by fluoxetine. Pharmacology Biochemistry and Behavior. 69(1-2). 189–193. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026